Waksman's 1943 discovery of streptomycin, and the ensuing altercation with Albert Schatz about attribution, intellectual property and commercial exploitation of this early antibiotic. Waksman -who developed soil microbiology and recognized that actinomycetes bacteria are nature's drug store for antibiotics -assigned to Schatz, his graduate student, the search for compounds active against Gram-negative bacteria. Schatz soon came up with Streptomyces griseus as a source of streptomycin.
This drug, the lucrative patent for which lists both Schatz and Waksman as its inventors, turned out to be highly active against Mycobacterium tuberculosis. It was responsible for remarkable therapeutic successes
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until the emergence of streptomycinresistant strains and isoniazid, an antibiotic used in combination therapy, in the early 1950s.
Drawing on historical records and interviews with Schatz's widow, the author lays out a plausible and fascinating story. The failure to communicate and manage expectations led to a painful clash between Schatz and Waksman. A culture that viewed the appropriation of subordinates' discoveries by laboratory chiefs as legitimate deepened the chasm.
Schatz's attempts to redress the perceived injustice -including a lawsuit against Waksman and Rutgers University in New Brunswick, New Jersey, later settled out of court -probably excluded him from academic positions to which he was entitled by talent and previous accomplishment. Reclamations of this type inevitably invite the opprobrium of the larger scientific community, not unlike the fate of many a whistle-blower similarly castigated for attempting to right a wrong. On the fiftieth anniversary of streptomycin's discovery, however, Rutgers finally awarded Schatz its highest decoration: the Rutgers University Medal.
Meyers's second story deals with the development of nuclear magnetic resonance (NMR) imaging as a tool in medical diagnostics, featuring physician Raymond Damadian and his battle with the late Paul Lauterbur, a chemist. This is the livelier portion of the book. Meyers -as a radiologist, effectively gardening in his own backyardhad the added benefit of interviewing both Damadian and Lauterbur.
With physicist Peter Mansfield, Lauterbur in 2003 bested Damadian to Nobel recognition of magnetic resonance imaging (MRI). This outcome prompted the appearance of full-page ads financed by the Friends of Raymond Damadian in a number of newspapers, including The New York Times.
As Meyers shows, Damadian was the first to suggest using NMR in imaging to distinguish healthy from cancerous tissues. But he could not claim to have made the essential steps leading to wider practicability of the method. He built a massive machine, 'Indomitable' , a prototype of which included a permanent magnet, as well as cardboard and copper foil components. Damadian used this monster to produce a low-resolution image of postdoc Larry Minkoff 's chest -which was, indeed, a first. However, many More generally, Meyers uses Prize Fight to muse on the obsession with awards and publication in top-flight periodicals, which can ultimately devalue the passion and ingenuity of so many who will never share that limelight. External validation by one's peers is an important, but not the sole, driver of ambition. Taken to pathological extremes, the drive to satisfy this need fuels unethical behaviour and scientific misconduct. Those victimized by it may bear permanent scars or decide to leave science entirely. Milder cases abound. Disagreements and fights over authorship, priority and recognition occur wherever science is practised.
Meyers emphasizes the human nature of scientific pursuit. He reminds us that the individual scientist's contribution is ephemeral: the field moves on. Moreover, every scientist who assembles and leads a team of graduate students, postdocs and technicians has to contend with issues of priority, authorship and, less frequently, assignment of intellectual-property rights. The book has yet to be written that lays out such points of friction for the kinds of research that will never be recognized by the Nobel committee, yet drive entire disciplines relentlessly forward -a category into which most of the science that has a positive impact on society probably falls. In the airline industry and medicine, checklists have become an essential step in preventing human error, whether in tightening bolts or measuring drug dosages. In the coda to Prize Fight, Meyers provides a checklist of sorts on how to avoid landing oneself in the intellectual and emotional morass that permanently colours the outlook of deserving but unrecognized scientists.
This starts with being aware of the problem, making an effort to be consistent in attribution of authorship, and setting criteria for establishing credit. Easier said than done: these issues are unlikely to disappear any time soon. But we ignore them at the risk of creating toxic working environments. ■ £14.99 (2012) For years, Kristen Iversen's mother thought that the industrial complex in their small Colorado town manufactured cleaning agents. But this was Rocky Flats -the US government facility where the plutonium 'pits' of nuclear weapons were manufactured. And, as Iversen reveals, it was plagued by safety issues. Among the appalling twists in this tale are high levels of testicular cancer among teenage boys in the area. After an inter-agency raid in 1989, pit production ceased; but Rocky Flats makes for a story with a long half-life. The 'Jim twins' constituted a watershed in the nature-nurture debate. When Jim Lewis and Jim Springer -twins separated at four months -were reunited at 39, both were found to have loved maths, worked as sheriffs and practised carpentry, among other startling parallels. The case underlined the importance of genetics and led to the Minnesota Study of Twins Reared Apart. In this inclusive overview, Nancy Segal, director of the Twin Studies Center at California State University, Fullerton, examines the study that turned ideas on parenting, teaching, health and sexual orientation upside down.
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SuperFuel: Thorium, the Green Energy Source for the Future Richard Martin Palgrave MacMillan 272 pp. £18.99 (2012) Post-Fukushima, uranium-powered plants face being phased out in many countries. But there is a nuclear alternative, argues cleanenergy-research analyst Richard Martin: thorium. Less volatile than uranium, four times as abundant, energy-dense and efficient, thorium has major potential, not least because liquid fluoride thorium reactors create no nuclear waste. Martin's investigation reveals how the technology, developed at Oak Ridge National Laboratory in Tennessee, was dropped by President Richard Nixon in 1972 -and how interest is now picking up in China, India and elsewhere.
"Obsession with awards can devalue the passion and ingenuity of so many who will never share that limelight."
